ALXN
Assenagon Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,426,193
| Closed | -$262M | – | 1448 |
|
|
2021
Q2 | $262M | Buy |
+1,426,193
| New | +$262M | 0.89% | 12 |
|
|
2021
Q1 | – | Sell |
-363,434
| Closed | -$56.8M | – | 1314 |
|
|
2020
Q4 | $56.8M | Sell |
363,434
-351,606
| -49% | -$54.9M | 0.25% | 61 |
|
|
2020
Q3 | $81.8M | Buy |
715,040
+337,045
| +89% | +$38.6M | 0.46% | 27 |
|
|
2020
Q2 | $42.4M | Buy |
+377,995
| New | +$42.4M | 0.27% | 53 |
|
|
2020
Q1 | – | Sell |
-102,779
| Closed | -$11.1M | – | 1008 |
|
|
2019
Q4 | $11.1M | Sell |
102,779
-20,477
| -17% | -$2.21M | 0.07% | 143 |
|
|
2019
Q3 | $12.1M | Buy |
123,256
+106,189
| +622% | +$10.4M | 0.08% | 125 |
|
|
2019
Q2 | $2.24M | Buy |
+17,067
| New | +$2.24M | 0.02% | 453 |
|
|
2019
Q1 | – | Sell |
-104,434
| Closed | -$10.2M | – | 1137 |
|
|
2018
Q4 | $10.2M | Sell |
104,434
-17,721
| -15% | -$1.73M | 0.12% | 111 |
|
|
2018
Q3 | $17M | Sell |
122,155
-191,289
| -61% | -$26.6M | 0.17% | 88 |
|
|
2018
Q2 | $38.9M | Buy |
313,444
+241,846
| +338% | +$30M | 0.45% | 37 |
|
|
2018
Q1 | $7.98M | Sell |
71,598
-431,277
| -86% | -$48.1M | 0.1% | 135 |
|
|
2017
Q4 | $60.1M | Sell |
502,875
-381,275
| -43% | -$45.6M | 0.62% | 8 |
|
|
2017
Q3 | $124M | Buy |
884,150
+864,967
| +4,509% | +$121M | 1.15% | 9 |
|
|
2017
Q2 | $2.33M | Buy |
+19,183
| New | +$2.33M | 0.05% | 58 |
|